Bohui Innovation: Announcement on the resignation of non-independent directors and the by-election of non-independent directors
Securities code: 300318 Securities abbreviation: Bohui Innovation Announcement number: Lin 2025-040
Beijing Bohui Innovation Biotechnology Group Co., Ltd.
Announcement on the resignation of non-independent directors and the by-election of non-independent directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Regarding the resignation of the company’s non-independent directors
The board of directors of Beijing Boxui Innovation Biotechnology Group Co., Ltd. (hereinafter referred to as the "Company") recently received written resignation reports from non-independent directors Mr. Zeng Chenglin and Ms. Shen Yong. Mr. Zeng Chenglin applied to resign as a non-independent director, a member of the Audit Committee and a member of the Strategy Committee of the 8th Board of Directors of the Company due to work adjustment; Ms. Shen Yong applied to resign as a non-independent director and a member of the Strategy Committee of the 8th Board of Directors of the Company due to work adjustment. After his resignation, Mr. Zeng Chenglin will still serve as the deputy general manager and chief engineer of the biological products division of the company, and Ms. Shen Yong will not hold any position in the company. The resignations of Mr. Zeng Chenglin and Ms. Shen Yong did not cause the company's board of directors to fall below the legal minimum number of members, and did not affect the normal operation of the company's board of directors. According to relevant regulations, his resignation report will take effect from the date it is delivered to the board of directors. The original term of directors of Mr. Zeng Chenglin and Ms. Shen Yong will end on the expiration date of the company’s eighth session of the board of directors (i.e. June 28, 2026). Mr. Zeng Chenglin and Ms. Shen Yong have completed the work handover in accordance with the company's relevant regulations on resignation management.
As of the disclosure date of this announcement, Mr. Zeng Chenglin and Ms. Shen Yong do not hold shares of the company, and there are no commitments that should be performed but have not been performed. The company and the board of directors express their sincere gratitude to Mr. Zeng Chenglin and Ms. Shen Yong for their contributions to the development of the company during their tenure as directors of the company.
2. Regarding the by-election of non-independent directors
In order to improve the corporate governance structure and ensure the normal operation of the company's board of directors, in accordance with the relevant provisions of the "Company Law of the People's Republic of China", the "Shenzhen Stock Exchange GEM Stock Listing Rules" and the "Articles of Association", and after the qualification review of the nomination committee of the company's board of directors, the company in November 2025 The 15th meeting of the 8th Board of Directors was held on the 13th, and the "Proposal on the By-election of Non-Independent Directors" was reviewed and approved, and Mr. Diao Jupeng was agreed to be nominated as a candidate for non-independent directors of the 8th Board of Directors (resume attached), and submitted to the company's general meeting of shareholders for election, with a term starting from Securities Code: 300318 Securities Abbreviation: Bohui Innovation Announcement Number: Lin 2025-040
From the date of review and approval of the company's first extraordinary shareholders' meeting in 2025 to the expiration of the company's eighth session of the board of directors.
Mr. Diao Jupeng has the qualifications suitable for the exercise of his powers, and there are no circumstances that prohibit him from serving as a director of the company as stipulated in the Company Law of the People's Republic of China, the Shenzhen Stock Exchange GEM Stock Listing Rules, the Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies and the Articles of Association. The qualifications and nomination procedures of non-independent director candidates are in compliance with the Company Law, the Articles of Association and other relevant regulations.
After the completion of this by-election, the number of directors who are also senior managers of the company and employee representatives on the board of directors will not exceed one-half of the total number of directors of the company.
Announcement is hereby made.
Board of Directors of Beijing Bohui Innovation Biotechnology Group Co., Ltd.
November 14, 2025
Securities code: 300318 Securities abbreviation: Bohui Innovation Announcement number: Lin 2025-040
Attachments:
Resume
Diao Jupeng: Male, born in 1990, Chinese nationality, no permanent residence abroad, doctorate degree. He once served as an industry researcher at Debon Securities, Huatai Securities, and Industrial Securities. Currently, he is the deputy director of the Capital and Investment Management Center of Inner Mongolia Junzheng Group Enterprise Management (Beijing) Co., Ltd.
As of the disclosure date of this announcement, Mr. Diao Jupeng does not hold any shares of the company and has no relationship with the company’s controlling shareholders, actual controllers, shareholders holding more than 5% of the shares, or current directors and senior managers of the company. Mr. Diao Jupeng is not prohibited from serving as a director as stipulated in the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies"; he has not been punished by the China Securities Regulatory Commission and other relevant departments or disciplinary sanctions by the stock exchange, and has not been investigated by judicial authorities for suspected crimes or suspected of violating laws. The China Securities Regulatory Commission has filed a case for investigation in violation of laws and regulations, but no clear conclusion has been reached; there has not been any situation that has been publicized by the China Securities Regulatory Commission on the securities and futures market illegal and untrustworthy information public inquiry platform or included in the list of dishonest persons subject to enforcement by the People's Court, and the qualifications meet the requirements of relevant laws, administrative regulations, departmental rules, normative documents, etc.